Taking Answers Home: Patient Advocates at the AACR Annual Meeting 2024
Patient advocates at the AACR Annual meeting 2024 brought their perspectives to cancer researchers.
Patient advocates at the AACR Annual meeting 2024 brought their perspectives to cancer researchers.
As we enter the winter holiday season, it’s time for the latest edition of Editors’ Picks, our monthly staple...
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
With coronavirus infections on the rise, we all feel the strain of the pandemic. The stress has deepened for those who are caring for people who are...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
In June 2020, the American Association for Cancer Research (AACR) hosted the second class of Global Scholar-In-Training Awardees (GSITA) during...
The screen goes blue, that unmistakable tune starts playing, and the voice of Johnny Gilbert announces, “This. Is. Jeopardy!” We meet the contestants. We hear...
In 2019, Michael D. Story, PhD, vice chair of the Department of Radiation Oncology and chief of the Division of Molecular Radiation Biology at UT Southwestern Medical Center, was one of...
Guest post by Emil Lou, MD, PhD On October 7, 2020, the world awoke to news that the Royal...
Guest post by David Virshup, MD Singapore will hold its 12th Frontiers in Cancer Science (FCS) conference virtually Nov....